All participants were 19 years of age or older
La semaglutida pertenece a una clase de medicamentos que imitan una hormona natural del organismo
A landmark trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, North Carolina residents across the state, from Asheville to Wilmington, have real, practical access to tirzepatide today
Firstly, we noted a change in clinical practice over the time of the trial, with a general preference for a LSG or RYGB procedure compared to LAGB, especially in participants with T2DM
However, if you desire more weight loss, you may need longer than 6 months